FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

23826011000001102: Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Feb 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77452601000001115 Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78251301000001111 Co-amilofruse 2.5mg/20mg tablets (DE Pharmaceuticals) 56 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Is a Co-amilofruse 2.5mg/20mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Has AMP Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Has specific active ingredient Furosemide true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Has specific active ingredient Amiloride hydrochloride true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amilofruse 2.5mg/20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start